Skip to content

Anacor Pharmaceuticals, Inc.

CIK 0001411158

← back to feed
Revenue (TTM)
$78.69M
−13.6% YoY Q1 May 2016
Net Income (TTM)
—
Q1 May 2016
EPS Diluted (TTM)
−$1.39
+32.5% YoY Q1 May 2016
Gross Margin
96.2%
Q1 May 2016
Operating Margin
-68.2%
Q1 May 2016
Net Margin
—
Q1 May 2016
Free Cash Flow (TTM)
—
Q1 May 2016
Cash
$24.97M
Q1 May 2016
Total Debt
—
Q1 May 2016
Shares Outstanding
45.37M sh
Q1 May 2016

Revenue & Net Income

EPS (Diluted)

Margins

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings